These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6113729)

  • 1. Incidence of tardive dyskinesia in patients receiving depot neuroleptic injection.
    Gibson AC
    Acta Psychiatr Scand Suppl; 1981; 291():111-6. PubMed ID: 6113729
    [No Abstract]   [Full Text] [Related]  

  • 2. Depot injections and tardive dyskinesia.
    Gibson AC
    Br J Psychiatry; 1978 Oct; 133():361-5. PubMed ID: 709010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in oro-facial tardive dyskinesia during depot antipsychotic drug treatment.
    Barnes TR; Wiles DH
    Psychopharmacology (Berl); 1983; 81(4):359-62. PubMed ID: 6140703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive dyskinesia and current dose of neuroleptic drugs.
    Kolakowska T; Williams AO; Ardern M
    Arch Gen Psychiatry; 1985 Sep; 42(9):925. PubMed ID: 2864034
    [No Abstract]   [Full Text] [Related]  

  • 5. Disturbances of liver function of long acting neuroleptic drugs.
    Nolen WA; Börger J
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Jul; 11(4):199-204. PubMed ID: 674355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationalizing neuroleptic polypharmacy in chronic schizophrenics: effects of changing to a single depot preparation.
    Soni SD; Sampath G; Shah A; Krska J
    Acta Psychiatr Scand; 1992 May; 85(5):354-9. PubMed ID: 1351333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables.
    Ezrin-Waters C; Seeman MV; Seeman P
    J Clin Psychiatry; 1981 Jan; 42(1):16-22. PubMed ID: 6109715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia in outpatients on depot phenothiazine.
    Neehall J
    West Indian Med J; 1989 Dec; 38(4):228-33. PubMed ID: 2576166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tardive dystonia: a rare side effect after long-term neuroleptic treatment].
    Bartels M; Riffel B; Stöhr M
    Nervenarzt; 1982 Nov; 53(11):674-6. PubMed ID: 6129578
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidemiology and pathophysiology of tardive dyskinesias.
    Klawans HL; Tanner CM; Goetz CG
    Adv Neurol; 1988; 49():185-97. PubMed ID: 2894124
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fluspirilene--safe weekly tranquilizer?].
    Kuhn W; Wöhrle M; Müller T; Welter F
    Nervenarzt; 1997 Jun; 68(6):528. PubMed ID: 9312689
    [No Abstract]   [Full Text] [Related]  

  • 12. Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.
    Kane JM; Smith JM
    Arch Gen Psychiatry; 1982 Apr; 39(4):473-81. PubMed ID: 6121548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tardive dyskinesia and current dose of neuroleptic drugs.
    Kolakowska T; Williams AO; Ardern M
    Arch Gen Psychiatry; 1986 Jun; 43(6):614. PubMed ID: 2871820
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic drugs: how to reduce the risk of tardive dyskinesia.
    DeVeaugh-Geiss J
    Geriatrics; 1979 Jul; 34(7):59-61, 66. PubMed ID: 36330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical, and drug history variables.
    Mukherjee S; Rosen AM; Cardenas C; Varia V; Olarte S
    Arch Gen Psychiatry; 1982 Apr; 39(4):466-9. PubMed ID: 6121547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of obesity in patients receiving depot antipsychotics.
    Silverstone T; Smith G; Goodall E
    Br J Psychiatry; 1988 Aug; 153():214-7. PubMed ID: 2908236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of tardive dyskinesia in fluphenazine-treated patients.
    Yassa R; Iskandar H; Ally J
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):17S-20S. PubMed ID: 3220966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study of tardive dyskinesia development: preliminary results.
    Kane JM; Woerner M; Weinhold P; Wegner J; Kinon B
    J Clin Psychopharmacol; 1982 Oct; 2(5):345-9. PubMed ID: 6127353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depot neuroleptic therapy: an underutilized treatment option.
    Glazer WM; Kane JM
    J Clin Psychiatry; 1992 Dec; 53(12):426-33. PubMed ID: 1362569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent tardive dyskinesia in randomly assigned neuroleptic reduction, neuroleptic nonreduction, and no-neuroleptic history groups: preliminary results.
    Kalachnik JE; Harder SR; Kidd-Nielsen P; Errickson E; Doebler M; Sprague RL
    Psychopharmacol Bull; 1984; 20(1):27-32. PubMed ID: 6144132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.